The SPOT-studies aim to improve the quality of care for women with hypertensive disorders of pregnancy. We have four overall objectives:
- To externally validate the fullPIERS and miniPIERS prediction models, and develop a simple, user friendly, numeric Severe Pre-eclampsia adverse Outcome Triage (SPOT) score to assist clinical decision making in severe early pre-eclampsia (SPOT-VAL).
- To quantify the relationship between fetal (and maternal) APOL1 status and preeclampsia and assess whether this can predict pre-eclampsia (SPOT-BIO).
- To understand the views on ‘good care’ of various stakeholders in the care of Hypertension Disorders in Pregnancy (HDP): health professionals, health management and pregnant women themselves.
- To assess impact of SPOT-score combined with shared-decision making tool implementation (SPOT-impact).
- To assess the incidence of mental health disorders among women with pregnancies complicated by an early HDP.
The SPOT-studies are funded by: the Bill & Melinda Gates Foundation, Dutch Research Council (NWO), University of Tennessee and the UMC Utrecht; with extensive in-kind support from all consortium members.
For information about the study’s progress and what’s new:
Sign up for our monthly NEWSLETTER!
Here are our previous newsletter editions:
October 2019
November 2019
December 2019
January 2020
Severe Pre-eclampsia adverse Outcome Triage (SPOT) studies 